ADRC News

Image
Stock photo of a couple walking on a trail
Carey Gleason, PhD, MS, and her research team’s African Americans Fighting Alzheimer's in Midlife (AA-FAIM) study is entering its second, five-year cycle and they are focused on making Alzheimer’s research more inclusive. 
Image
Graphic image with headshot of Dr. Maria Mora Pinzon
Maria Mora Pinzon, MD, MS, FACPM, was recently appointed to assistant professor on the tenure track in the Division of Geriatrics and Gerontology at the University of Wisconsin School of Medicine and Public Health.
Image
Graphic image for Black History Month 2023 that features the Wisconsin ADRC logo and marquee that states Black History Month
The Wisconsin Alzheimer's Disease Research Center gratefully recognizes, along with the nation, that February is the traditional Black History Month celebration to acknowledge the contributions of African Americans to the United States of America.
Image
Photograph of Dr. Tobey Betthauser presenting at the 2023 HAI conference
Researchers from the University of Wisconsin–Madison and Wisconsin Alzheimer’s Disease Research Center (ADRC) recently presented at the 15th Annual Edition of the Human Amyloid Imaging (HAI) conference.
Image
Stock photo of a man looking through a microscopt
The Wisconsin Alzheimer’s Disease Research Center (ADRC) is pleased to announce three Developmental Projects awardees, selected for their research targeting Alzheimer’s disease and related dementias.
Image
Nathaniel Chin, MD, at his desk with the Wisconsin Public Radio logo on his computer
Nathaniel Chin, MD, joined host Rob Ferrett on the call-in program “Central Time” on The Ideas Network of Wisconsin Public Radio.
Image
A picture containing text, indoor, computer, image of Dr. Cynthia Carlsson
Cynthia Carlsson, MD, MS, was recently interviewed by CBS 58 News in Milwaukee about the U.S. Food and Drug Administration (FDA) approval of Leqembi (lecanemab), which showed a reduction of clinical decline in a study of people with early Alzheimer’s disease.
Image
Graphic image noting the words FDA Approved
On January 6, the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of Alzheimer’s disease. Leqembi is the second of a new category of medications approved for Alzheimer’s disease that target the fundamental pathophysiology of the disease.
Image
Graphic image with headshot of Dr. Sanjay Asthana
Sanjay Asthana, MD, professor, and Duncan G. and Lottie H. Ballantine Chair, Geriatrics and Gerontology, has been invited by the US Secretary of Health and Human Services and the Director of the National Institutes of Health (NIH) to serve a four-year appointment on the National Advisory Council on Aging.
Image
The Dementia Matters logo against a white background with red and black fireworks around the edges. Above, text reads "Top 5 Episodes of 2022". The Wisconsin ADRC logo sits in the lower left-hand corner.
In 2022, 'Dementia Matters' released 31 episodes about Alzheimer's disease research advances, caregiver strategies and prevention tips from local and national dementia experts. Listed here are the five most popular 'Dementia Matters' episodes of 2022.